Literature DB >> 18345469

[Development of national guidelines for depression].

Martin Härter1, C Klesse, I Bermejo, M Lelgemann, S Weinbrenner, G Ollenschläger, I Kopp, M Berger.   

Abstract

Depressive disorders rank among the most frequent causes of consultation and diseases in health care. Although they are treatable, there is further need to optimize diagnostics and therapy, despite sizable progress in recent years. The implementation of evidence- and consensus-based guidelines is an appropriate measure to improve care for depressive patients. An evidence-based guideline for depression is currently being developed for Germany. In order to ensure its acceptance and a wide dissemination, this guideline will be adopted in consensus by all relevant health care providers in this field. According to this, it is a future challenge to anchor guideline-based diagnostics and treatment in routine care.

Entities:  

Mesh:

Year:  2008        PMID: 18345469     DOI: 10.1007/s00103-008-0514-9

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  9 in total

1.  [Methodological fundamentals of the development of the guideline].

Authors:  W Häuser; K Bernardy; H Wang; I Kopp
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

2.  Unipolar depression: diagnostic and therapeutic recommendations from the current S3/National Clinical Practice Guideline.

Authors:  Martin Härter; Christian Klesse; Isaac Bermejo; Frank Schneider; Mathias Berger
Journal:  Dtsch Arztebl Int       Date:  2010-10-08       Impact factor: 5.594

Review 3.  The role of the "International Classification of Functioning, Disability and Health, ICF" in the description and classification of mental disorders.

Authors:  Stefanie Baron; Michael Linden
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

4.  [Methodology report of the 2017 guidelines on fibromyalgia syndrome].

Authors:  W Häuser; M Nothacker
Journal:  Schmerz       Date:  2017-06       Impact factor: 1.107

5.  Long-term opioid use in non-cancer pain.

Authors:  Winfried Häuser; Fritjof Bock; Peter Engeser; Thomas Tölle; Anne Willweber-Strumpfe; Frank Petzke
Journal:  Dtsch Arztebl Int       Date:  2014-10-24       Impact factor: 5.594

6.  [Evidence-based therapy of depression: S3 guidelines on unipolar depression].

Authors:  M Härter; C Klesse; I Bermejo; T Bschor; J Gensichen; T Harfst; M Hautzinger; C Kolada; I Kopp; C Kühner; M Lelgemann; J Matzat; B Meyerrose; C Mundt; W Niebling; G Ollenschläger; R Richter; H Schauenburg; H Schulz; S Weinbrenner; F Schneider; M Berger
Journal:  Nervenarzt       Date:  2010-09       Impact factor: 1.214

Review 7.  [Methodology of the development of the updated LONTS guidelines for long-term administration of opioids in noncancer pain].

Authors:  W Häuser; P Klose; P Welsch; F Petzke; M Nothacker; I Kopp
Journal:  Schmerz       Date:  2015-02       Impact factor: 1.107

8.  Treatment patterns in inpatient depression care.

Authors:  Alessa von Wolff; Ramona Meister; Martin Härter; Levente Kriston
Journal:  Int J Methods Psychiatr Res       Date:  2015-08-18       Impact factor: 4.035

Review 9.  Update on Treatment Guideline in Fibromyalgia Syndrome with Focus on Pharmacology.

Authors:  Sanam Kia; Ernet Choy
Journal:  Biomedicines       Date:  2017-05-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.